These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10354663)

  • 1. Is psychopharmacological treatment effective for the symptoms of borderline personality disorder (BPD)?
    Paris J
    J Psychiatry Neurosci; 1999 May; 24(3):262. PubMed ID: 10354663
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of borderline personality disorder.
    Hirschfeld RM
    J Clin Psychiatry; 1997; 58 Suppl 14():48-52; discussion 53. PubMed ID: 9418746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any drug treatment of choice for the borderline patient?
    Soloff PH
    Acta Psychiatr Scand Suppl; 1994; 379():50-5. PubMed ID: 8010152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art in the pharmacologic treatment of borderline personality disorder.
    Feurino L; Silk KR
    Curr Psychiatry Rep; 2011 Feb; 13(1):69-75. PubMed ID: 21140245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsive aggression in borderline personality disorder.
    Goodman M; New A
    Curr Psychiatry Rep; 2000 Feb; 2(1):56-61. PubMed ID: 11122933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E
    J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of borderline personality disorder.
    Ripoll LH
    Dialogues Clin Neurosci; 2013 Jun; 15(2):213-24. PubMed ID: 24174895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder.
    Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Vielma W; Montes C; Pumarino L; Roa N
    Actas Esp Psiquiatr; 2007; 35(6):387-92. PubMed ID: 17597424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications in the treatment of borderline personality disorder 2006.
    Mercer D
    Curr Psychiatry Rep; 2007 Feb; 9(1):53-62. PubMed ID: 17257515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in the pharmacotherapy of personality disorders.
    Markovitz PJ
    J Pers Disord; 2004 Feb; 18(1):90-101. PubMed ID: 15061346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics?
    Abraham PF; Calabrese JR
    J Affect Disord; 2008 Nov; 111(1):21-30. PubMed ID: 18304647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.
    Bellino S; Paradiso E; Bozzatello P; Bogetto F
    J Psychopharmacol; 2010 Mar; 24(3):333-9. PubMed ID: 18719047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on Current Care Guideline: Borderline personality disorder].
    Korkeila J; Kantojärvi L; Koivisto M; Karlsson H; Keinänen M; Lindeman S; Nikkilä H; Stenberg JH; Taiminen T; Jousilahti P; Tuunainen A
    Duodecim; 2015; 131(16):1484-5. PubMed ID: 26485941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine for the treatment of impulsive aggression and affective symptoms in a patient with borderline personality disorder comorbid with body dysmorphic disorder.
    Pavlovic ZM
    J Neuropsychiatry Clin Neurosci; 2008; 20(1):121-2. PubMed ID: 18305309
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopharmacology of borderline personality disorder.
    Raj YP
    Curr Psychiatry Rep; 2004 Jun; 6(3):225-31. PubMed ID: 15142476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E; Lemelin S
    J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of personality disorder.
    Bateman AW; Gunderson J; Mulder R
    Lancet; 2015 Feb; 385(9969):735-43. PubMed ID: 25706219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.